Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment for women news

Show

From To
Option B+: Understanding perspectives and experiences of women living with HIV

Option B+ is a prevention of vertical transmission approach for expectant mothers living with HIV in which women are immediately offered treatment for life regardless of their CD4 count. This approach offers advantages such as protection of partner(s) and (unborn) child, as well as benefits to the woman's health, but also carries with it risks. In the attached publication, GNP+ and ICW report on the results of 8 different focus group discussions that discussed these issues in Uganda and Malawi.

Published
12 April 2013
From
GNP+
Long-term suppression of viral load and sustained CD4 cell increase reduce risk of cervical HPV infection for HIV-positive women

HIV therapy that achieves long-term suppression of viral load and sustained immune reconstitution reduces the risk of persistent cervical infection with high-risk strains of human papillomavirus (HPV), research

Published
01 April 2013
By
Michael Carter
HIV Drug Not Tied to Premature Births

Pregnant HIV-infected women treated with a lopinavir/ritonavir (Kaletra)-based antiretroviral regimen are at no greater risk of delivering a preterm baby than similar pregnant women given an efavirenz (Sustiva)-based treatment, researchers said here.

Published
10 March 2013
From
MedPage Today
HIV and TB in Practice for nurses: Pregnancy and TB/HIV

This article explains how to prevent and treat TB in pregnant women to protect both mother and child.

Published
14 February 2013
From
HIV & AIDS treatment in practice
Pregnancy does not increase risk of nevirapine side-effects

Pregnancy does not increase the risk of nevirapine (Viramune) associated side-effects, according to the results of a systematic review and meta-analysis published in the online edition of AIDS. Investigators

Published
07 February 2013
By
Michael Carter
Point-of-care (POC) diagnostics are essential to achieving an AIDS-free generation and improving outcomes in HIV-exposed children

This edition reviews recent evidence on point-of-care testing, on tests in development, and looks at experience of optimising performance of dried blood spot sampling.

Published
14 December 2012
From
HIV & AIDS treatment in practice
New fixed-dose combination pills measure up to Atripla - corrected version*

Several studies, or updates of studies, comparing newer against older drug regimens were presented at the Eleventh International Congress on Drug Therapy in HIV Infection last week.

Published
20 November 2012
By
Gus Cairns
Lack of understanding of treatment benefits may discourage women with HIV from having children – and could increase the risk of vertical transmission

Two papers presented at the eleventh International Congress on Drug Therapy in HIV Infection this week in Glasgow suggest that some women with HIV may not have

Published
16 November 2012
By
Gus Cairns
Adverse birth outcomes more frequent in women exposed to ART during pregnancy, largest-ever study confirms

Among HIV-infected women in Botswana, starting combination antiretroviral therapy during pregnancy was associated with an increased risk for adverse birth outcomes, including pre-term delivery, small for gestational age,

Published
30 October 2012
By
Carole Leach-Lemens
The generic generation

In the next few years, some of the most widely used HIV drugs will come off patent in the UK. Gus Cairns asks: what are the

Published
22 October 2012
From
HIV treatment update
← First12345...7Next →

Filter by country